TY - CHAP M1 - Book, Section TI - Heart Disease Year in Review A1 - Papadakis, Maxine A. A1 - McPhee, Stephen J. A1 - Rabow, Michael W. A1 - McQuaid, Kenneth R. PY - 2023 T2 - Current Medical Diagnosis & Treatment 2023 AB - The USPSTF issued new guidance on the use of aspirin for primary prevention of cardiovascular events; patients aged 40–49 years should have a shared decision-making conversation regarding the potential risks and benefits of initiating aspirin therapy for primary prevention, and patients aged 60 years or older should not initiate aspirin for primary prevention of CVD. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessmedicine.mhmedical.com/content.aspx?aid=1193123611 ER -